6 news items
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
. Ligand is not responsible for, and has no role in, the development of such products or programs.
Ligand
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
AGEN
LGND
7 May 24
immune activator (antibody) designed to boost both innate and adaptive anti-tumor immune responses. Its novel design leverages mechanisms of action
Ligand Pharmaceuticals Announces Launch Of Pelthos Therapeutics To Accelerate Commercialization Of ZELSUVMI, Scott Plesha Named CEO
LGND
3 Apr 24
Dermatologics, a division of Watson Laboratories, and in commercial roles of increasing responsibility at Solvay Pharmaceuticals."I am excited
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMIâ„¢
LGND
3 Apr 24
Dermatologics, a division of Watson Laboratories, and in commercial roles of increasing responsibility at Solvay Pharmaceuticals
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
AAN
AHCO
ALPP
27 Feb 24
it received a Complete Response Letter from the FDA for the New Drug Application for roluperidone for the treatment of negative symptoms in patients
8gk00ow 7x5bl3rve51vvtrquut0yaw5wy
ALDX
LGND
MRK
27 Feb 24
(NASDAQ:ALDX) announced receipt of a Complete Response Letter (CRL) from the FDA for the NDA of reproxalap, an investigational drug
- Prev
- 1
- Next